Breast Cancer Symposium leads way to new treatments
More than 7,000 physicians and researchers from around the world will converge on the Henry B. Gonzalez Convention Center, 800 E. Market St., Dec. 4-8, to attend the San Antonio Breast Cancer Symposium® (SABCS®).
Founded, owned and operated by UT Health San Antonio, SABCS began in 1977 as a one-day regional conference. Over the past 41 years, the meeting has grown into a five-day international conference with representatives from more than 80 countries. Fifty percent of attendees are from countries outside the U.S.
“SABCS is one of the largest breast cancer conference in the world,” said Virginia Kaklamani, M.D., professor of medicine and leader of the UT Health San Antonio breast cancer program, who serves as one of three co-leaders of the SABCS.
The basic scientists, physicians, clinical investigators and patient advocates who attend provide an estimated economic impact of more than $20 million, according to a 2015 economic study, said Symposium Director Rich Markow from UT Health San Antonio.
Economic benefits aside, said Ruben Mesa, M.D., FACP, director of UT Health San Antonio’s cancer center, “The science presented at the San Antonio Breast Cancer Symposium and the discussions they generate help advance the standard of care for cancer patients around the world.”